90792-69-1 Usage
General Description
Methyl 2-chlorobenzo[d]thiazole-6-carboxylate is a chemical compound that belongs to the thiazole family. It is an ester of 2-chlorobenzo[d]thiazole-6-carboxylic acid and methyl alcohol. methyl 2-chlorobenzo[d]thiazole-6-carboxylate is often used in organic synthesis and drug discovery as a building block for the synthesis of various pharmaceuticals and agrochemicals. It is known for its potential biological activities and is commonly utilized in the development of new drugs. The structure of this compound contains a thiazole ring, which is a key structural motif in many biologically active compounds. Due to its versatile applications, methyl 2-chlorobenzo[d]thiazole-6-carboxylate is an important chemical in the field of organic chemistry and drug development.
Check Digit Verification of cas no
The CAS Registry Mumber 90792-69-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,0,7,9 and 2 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 90792-69:
(7*9)+(6*0)+(5*7)+(4*9)+(3*2)+(2*6)+(1*9)=161
161 % 10 = 1
So 90792-69-1 is a valid CAS Registry Number.
InChI:InChI=1/C9H6ClNO2S/c1-13-8(12)5-2-3-6-7(4-5)14-9(10)11-6/h2-4H,1H3
90792-69-1Relevant articles and documents
TLR2 MODULATOR COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
-
Paragraph 001481-001482, (2021/12/08)
The present disclosure relates to compounds which modulate the activity of Toll-like receptor (TLR) proteins, including agonists or activators, partial agonists, and antagonists. Of particular interest of compounds that modulate the activity of TLR2, as well as methods of using such compounds to treat cancer and other disorders associated with a TLR2 pathway.
NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AS FXR MODULATORS
-
Paragraph 0112; 0113, (2018/05/24)
The present technology is directed to compounds, compositions, and methods related to modulation of FXR. In particular, the present compounds and compositions may be used to treat FXR-mediated disorders and conditions, including, e.g., liver disease, hype
